Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1228 (LINC01228) is a human long non-coding RNA (lncRNA) gene located at chromosome 16q23.2 (region chr16:79797826-79827185)[1][3][5]. It is classified as an intergenic lncRNA, a class of non-coding RNAs that do not encode proteins but can regulate gene expression and chromatin structure[9]. While dysregulation or genetic variants in some lincRNAs have been implicated in various cancers and other diseases, there is currently no direct evidence linking LINC01228 specifically to a characterized disease phenotype or as a therapeutic target[9]. LINC01228 may be listed in genome-wide association databases due to its genomic location and potential for containing or being near polymorphisms of interest, but its functional role remains largely undefined[1][7]. There are no known drugs or established biomarker roles for LINC01228, and it is not considered a therapeutic or diagnostic target at this time[5][3][9].
Not applicable (no drugs target this lncRNA; no mechanism of action described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1228 (LINC01228).